|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00876 KAISA HEALTH
Nominal 
0.025 0.000 (0.000%) | 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Turnover | 185,882 | -2.933% | 191,499 | 209,626 | 183,810 | 251,618 |
| Cost of Sales | (104,809) | -3.787% | (108,934) | (112,211) | (93,847) | (128,728) |
| Gross Profit | 81,073 | -1.807% | 82,565 | 97,415 | 89,963 | 122,890 |
| 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | (64,129) | -- | -- | -- | |
| Change in FV & Impairment on Others | (25,310) | -38.623% | (41,237) | 57,950 | (6,019) | (345,410) | |
| Profit / (Loss) on Disposal | 69,391 | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 6,046 | -- | (170,963) | 11,203 | (41,473) | (362,671) | |
| Taxation | 104 | -- | (1,169) | (23,526) | 778 | 7,625 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 1,318 | -97.300% | 48,814 | 14,682 | 1,003 | 373 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 7,468 | -- | (123,318) | 2,359 | (39,692) | (354,673) | |
| 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Net Finance Costs / (Income) | 594 | -87.429% | 4,725 | 6,864 | 440 | (8,892) |
| Depreciation & Amortisation | 17,887 | -42.875% | 31,312 | 27,390 | 20,520 | 14,751 |
| Directors' Emoluments | 18,105 | -21.701% | 23,123 | 20,446 | 25,154 | 12,063 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | 0.150 | -- | -2.450 | 0.050 | -0.790 | -7.030 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (0.007) | -- | (0.012) | (0.024) | (0.006) | (0.002) |
| NBV per share ($) | 0.098 | -- | 0.096 | 0.129 | 0.126 | 0.127 |
| Remarks: | Real time quote last updated: 25/11/2024 10:03 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -24,264,000 |
| %Change | -- |
| EPS / (LPS) | HKD -0.005 |
| NBV Per Share ($) | HKD 0.091 |